Cargando…

IL-32 promotes the occurrence of atopic dermatitis by activating the JAK1/microRNA-155 axis

BACKGROUND: This study aims to explore the mechanism of interleukin-32 (IL-32) affecting atopic dermatitis (AD) through the Janus-activated kinase-1 (JAK1)/microRNA-155 (miR-155) axis. METHODS: In this study, skin tissue samples and blood samples from normal subjects and patients with AD, human immo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Jing, Zhou, Bin, Wei, Zhu, Luo, Yongqi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097387/ https://www.ncbi.nlm.nih.gov/pubmed/35545774 http://dx.doi.org/10.1186/s12967-022-03375-x

Ejemplares similares

MicroRNAs in atopic dermatitis: A systematic review
por: Yu, Xin, et al.
Publicado: (2020)

The IL-4/-13 Axis and Its Blocking in the Treatment of Atopic Dermatitis
por: Pappa, Georgia, et al.
Publicado: (2022)

Profiling of Serum and Urinary MicroRNAs in Children with Atopic Dermatitis
por: Lv, Yani, et al.
Publicado: (2014)

Combination of FLG mutations and SNPs of IL-17A and IL-19 influence on atopic dermatitis occurrence
por: Klonowska, Jolanta, et al.
Publicado: (2021)

Efficacy and Safety of JAK1 Inhibitor Abrocitinib in Atopic Dermatitis
por: Iznardo, Helena, et al.
Publicado: (2023)

A New Horizon for Atopic Dermatitis Treatments: JAK Inhibitors
por: Tampa, Mircea, et al.
Publicado: (2023)

Regulation of Skin Barrier Function via Competition between AHR Axis versus IL-13/IL-4‒JAK‒STAT6/STAT3 Axis: Pathogenic and Therapeutic Implications in Atopic Dermatitis
por: Furue, Masutaka
Publicado: (2020)

Correction: Profiling of Serum and Urinary MicroRNAs in Children with Atopic Dermatitis
Publicado: (2015)

The severity of atopic dermatitis evaluated with the SCORAD index and the occurrence of bronchial asthma and rhinitis, and the duration of atopic dermatitis
por: Celakovská, Jarmilă, et al.
Publicado: (2016)

JAK–STAT signaling pathway in the pathogenesis of atopic dermatitis: An updated review
por: Huang, I-Hsin, et al.
Publicado: (2022)

Microbiome in the Gut-Skin Axis in Atopic Dermatitis
por: Lee, So-Yeon, et al.
Publicado: (2018)

Regulatory Mechanism of the IL-33–IL-37 Axis via Aryl Hydrocarbon Receptor in Atopic Dermatitis and Psoriasis
por: Tsuji, Gaku, et al.
Publicado: (2023)

IL-33/13 Axis and IL-4/31 Axis Play Distinct Roles in Inflammatory Process and Itch in Psoriasis and Atopic Dermatitis
por: Bodoor, Khaldon, et al.
Publicado: (2020)

Targeting IL-4 for the Treatment of Atopic Dermatitis
por: Chiricozzi, Andrea, et al.
Publicado: (2020)

Microbiota and IL-33/31 Axis Linkage: Implications and Therapeutic Perspectives in Atopic Dermatitis and Psoriasis
por: Bonzano, Laura, et al.
Publicado: (2023)

JAK-STAT Inhibitors in Atopic Dermatitis from Pathogenesis to Clinical Trials Results
por: Szalus, Krzysztof, et al.
Publicado: (2020)

Dupilumab therapy following JAK inhibitor withdrawal in moderate–severe atopic dermatitis
por: Kiely, Lisa, et al.
Publicado: (2022)

Optimal Use of Jak Inhibitors and Biologics for Atopic Dermatitis on the Basis of the Current Evidence
por: Kamata, Masahiro, et al.
Publicado: (2023)

IL‐20 promotes cutaneous inflammation and peripheral itch sensation in atopic dermatitis
por: Lu, Zhiping, et al.
Publicado: (2022)

Atopic dermatitis and autoimmunity: the occurrence of autoantibodies and their association with disease severity
por: Holmes, James, et al.
Publicado: (2019)

Mendelian randomization indicates that atopic dermatitis contributes to the occurrence of diabetes
por: Lu, Feiwei, et al.
Publicado: (2023)

Association between Stress and the HPA Axis in the Atopic Dermatitis
por: Lin, Tzu-Kai, et al.
Publicado: (2017)

MicroRNA-146a as a potential regulator involved in the pathogenesis of atopic dermatitis
por: Yan, Fenggen, et al.
Publicado: (2019)

A dysregulated sebum–microbial metabolite–IL-33 axis initiates skin inflammation in atopic dermatitis
por: Qiu, Zhuoqiong, et al.
Publicado: (2022)

Selective IL-13 inhibitors for the treatment of atopic dermatitis
por: Gonçalves, Francisca, et al.
Publicado: (2021)

The involvement of the JAK-STAT signaling pathway in chronic inflammatory skin disease atopic dermatitis
por: Bao, Lei, et al.
Publicado: (2013)

Portuguese recommendations for the treatment of atopic dermatitis with biologic therapy and JAK inhibitors in adult patients
por: Torres, Tiago, et al.
Publicado: (2021)

Potential Natural Biomolecules Targeting JAK/STAT/SOCS Signaling in the Management of Atopic Dermatitis
por: Kopalli, Spandana Rajendra, et al.
Publicado: (2022)

ΔNp63 regulates IL-33 and IL-31 signaling in atopic dermatitis
por: Rizzo, J M, et al.
Publicado: (2016)

MicroRNA Cross-Involvement in Autism Spectrum Disorders and Atopic Dermatitis: A Literature Review
por: Tonacci, Alessandro, et al.
Publicado: (2019)

MicroRNAs in Several Cutaneous Autoimmune Diseases: Psoriasis, Cutaneous Lupus Erythematosus and Atopic Dermatitis
por: Domingo, Sandra, et al.
Publicado: (2020)

Serum-Derived Neuronal Exosomal microRNAs as Stress-Related Biomarkers in an Atopic Dermatitis Model
por: Sung, Minkyoung, et al.
Publicado: (2021)

Antagonistic Interplay between MicroRNA-155 and IL-10 during Lyme Carditis and Arthritis
por: Lochhead, Robert B., et al.
Publicado: (2015)

The multiple roles of microRNA-155 in oncogenesis
por: Higgs, Gadareth, et al.
Publicado: (2013)

MicroRNA-155 expression with Brucella infection in vitro and in vivo and decreased serum levels of MicroRNA-155 in patients with brucellosis
por: Zhang, Xi, et al.
Publicado: (2022)

Role of microRNA-21 and microRNA-155 as biomarkers for bronchial asthma
por: ElKashef, Sabrin Mohamed Mohamed Abd Elhamed, et al.
Publicado: (2020)

The role of heterodimer IL-17-A/F in atopic dermatitis
por: Krzysiek, Joanna, et al.
Publicado: (2022)

MicroRNA-155 Promotes Autophagy to Eliminate Intracellular Mycobacteria by Targeting Rheb
por: Wang, Jinli, et al.
Publicado: (2013)

Simultaneous improvement of alopecia universalis and atopic dermatitis in a patient treated with a JAK inhibitor
por: Morris, Gabriela M., et al.
Publicado: (2018)

Emerging systemic JAK inhibitors in the treatment of atopic dermatitis: a review of abrocitinib, baricitinib, and upadacitinib
por: Nezamololama, Novin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sf899l40m0iro26gesm9lpirnh